Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
A clinical trial was designed to evaluate the efficacy and safety of cefotaxime, a new semisynthetic, broad-spectrum cephalosporin, in the therapy of community-and hospital-acquired pneumonias. Thirty-nine males (mean age, 65 years) were treated for 41 episodes of pneumonia. Only five patient did no...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1982
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181881/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6280600/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.21.2.327 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|